- Home
- GRML vs PAVM Comparison
GRML vs PAVM Comparison
Compare GRML & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GRML | PAVM |
|---|---|---|
| Founded | N/A | 2014 |
| Country | United States | United States |
| Employees | 5 | 41 |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.9M | 41.8M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | GRML | PAVM |
|---|---|---|
| Price | $0.23 | $5.95 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $65.00 |
| AVG Volume (30 Days) | ★ 3.3M | 23.4K |
| Earning Date | 05-13-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $603.94 |
| Revenue Next Year | N/A | $33.16 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.21 | $0.21 |
| 52 Week High | $0.55 | $28.44 |
Technical Indicators
Market Signals| Indicator | GRML | PAVM |
|---|---|---|
| Relative Strength Index (RSI) | 33.51 | 51.00 |
| Support Level | $0.21 | $0.32 |
| Resistance Level | $0.34 | $5.83 |
| Average True Range (ATR) | 0.04 | 0.60 |
| MACD | -0.00 | 0.22 |
| Stochastic Oscillator | 16.57 | 71.54 |
Price Performance
Historical ComparisonAbout GRML Greenland Mines Ltd. Common Stock
Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases - cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, EsoCheck, and the Veris Cancer Care Platform.